Cme (CME) Notes Payables (2009 - 2025)

Cme (CME) has 10 years of Notes Payables data on file, last reported at $750.0 million in Q1 2025.

• Notes Payables for Q1 2025 came in at $750.0 million, changed 0.09% year-over-year; the trailing twelve-month figure through Mar 2025 was $750.0 million (changed 0.09% YoY), and the FY2024 annual result was $749.8 million, changed N/A from the prior year.
• Notes Payables steadied at $750.0 million in Q1 2025 per CME's latest filing, from $749.8 million in the prior quarter.
• Over five years, Notes Payables peaked at $750.0 million in Q1 2025 and troughed at $14.5 million in Q3 2022.
• A 5-year average of $529.4 million and a median of $749.4 million in 2021 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2022 and 2024: Notes Payables plunged 98.06% in 2022, then soared 4496.93% in 2024.
• A 5-year view of Notes Payables shows it stood at $749.4 million in 2021, then sank by 97.86% to $16.0 million in 2022, then increased by 1.88% to $16.3 million in 2023, then soared by 4500.0% to $749.8 million in 2024, then advanced by 0.03% to $750.0 million in 2025.
• Business Quant data shows CME's Notes Payables at $750.0 million in Q1 2025, $749.8 million in Q4 2024, and $749.7 million in Q3 2024.